Clinical Nutrition Market Size, Industry Share & Growth 2024-2028

Global Clinical Nutrition Market Overview 2024-2028

IMARC Group, a leading market research company, has recently releases report titled “Clinical nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2028.” The study provides a detailed analysis of the industry, including the global Clinical nutrition market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Clinical nutrition refers to the branch of nutrition that focuses on the application of nutrition science and principles to promote optimal health and manage medical conditions in clinical settings. It involves assessing, diagnosing, and treating nutritional problems and developing personalized nutrition plans to support overall health and address specific medical conditions. It considers the unique nutritional needs of patients based on their age, sex, medical history, and specific requirements related to their condition. It is used in the prevention and management of various diseases and the recovery and rehabilitation of individuals with medical conditions.

The global clinical nutrition market size reached US$ 47.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 78.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.35% during 2024-2028.

Global Clinical Nutrition Market Trends and Drivers:

The surging prevalence of chronic conditions, such as diabetes, cardiovascular diseases, and cancer, which often require special dietary needs, and the rising aging population who are more prone to develop such diseases, represent one of the primary factors driving the demand for clinical nutrition around the world. Moreover, the increasing cases of food allergies and intolerances, such as gluten and lactose intolerance, are bolstering the market growth. In addition, the growing inclination towards personalized medicine is influencing the market positively. Apart from this, the rising number of preterm births and the inflating need for clinical nutrition in the pediatric medicine segment is favoring the growth of the market.

Global Clinical Nutrition Market 2024-2028 Analysis and Segmentation:

Top Key Players covered in this report are: Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc and Reckitt Benckiser Group PLC

The report segmented the market on the basis of region, product, route of administration, application and end user.

Breakup by Product:

Infant Nutrition

Parental Nutrition

Enteral Nutrition

Breakup by Route of Administration:

Oral

Enteral

Parenteral

Breakup by Application:

Cancer

Malnutrition

Metabolic Disorders

Gastrointestinal Disorders

Neurological Disorders

Others

Breakup by End User:

Pediatric

Adults

Geriatric

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Key highlights of the report:

Market Performance (2017-2022)

Market Outlook (2024- 2028)

Porter’s Five Forces Analysis

Market Drivers and Success Factors

SWOT Analysis

Value Chain

Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

1 Preface

2 Scope and Methodology

    2.1 Objectives of the Study

    2.2 Stakeholders

    2.3 Data Sources

        2.3.1 Primary Sources

        2.3.2 Secondary Sources

    2.4 Market Estimation

        2.4.1 Bottom-Up Approach

        2.4.2 Top-Down Approach

    2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

    4.1 Overview

    4.2 Key Industry Trends

5 Global Clinical Nutrition Market

    5.1 Market Overview

    5.2 Market Performance

    5.3 Impact of COVID-19

    5.4 Market Forecast

6 Market Breakup by Product

    6.1 Infant Nutrition

        6.1.1 Market Trends

        6.1.2 Market Forecast

    6.2 Parental Nutrition

        6.2.1 Market Trends

        6.2.2 Market Forecast

    6.3 Enteral Nutrition

        6.3.1 Market Trends

        6.3.2 Market Forecast

7 Market Breakup by Route of Administration

    7.1 Oral

        7.1.1 Market Trends

        7.1.2 Market Forecast

    7.2 Enteral

        7.2.1 Market Trends

        7.2.2 Market Forecast

    7.3 Parenteral

        7.3.1 Market Trends

        7.3.2 Market Forecast

8 Market Breakup by Application

    8.1 Cancer

        8.1.1 Market Trends

        8.1.2 Market Forecast

    8.2 Malnutrition

        8.2.1 Market Trends

        8.2.2 Market Forecast

    8.3 Metabolic Disorders

        8.3.1 Market Trends

        8.3.2 Market Forecast

    8.4 Gastrointestinal Disorders

        8.4.1 Market Trends

        8.4.2 Market Forecast

    8.5 Neurological Disorders

        8.5.1 Market Trends

        8.5.2 Market Forecast

    8.6 Others

        8.6.1 Market Trends

        8.6.2 Market Forecast

9 Market Breakup by End User

    9.1 Pediatric

        9.1.1 Market Trends

        9.1.2 Market Forecast

    9.2 Adults

        9.2.1 Market Trends

        9.2.2 Market Forecast

    9.3 Geriatric

        9.3.1 Market Trends

        9.3.2 Market Forecast

10 Market Breakup by Region

    10.1 North America

        10.1.1 United States

           10.1.1.1 Market Trends

           10.1.1.2 Market Forecast

        10.1.2 Canada

           10.1.2.1 Market Trends

           10.1.2.2 Market Forecast

    10.2 Asia-Pacific

        10.2.1 China

           10.2.1.1 Market Trends

           10.2.1.2 Market Forecast

        10.2.2 Japan

           10.2.2.1 Market Trends

           10.2.2.2 Market Forecast

        10.2.3 India

           10.2.3.1 Market Trends

           10.2.3.2 Market Forecast

        10.2.4 South Korea

           10.2.4.1 Market Trends

           10.2.4.2 Market Forecast

        10.2.5 Australia

           10.2.5.1 Market Trends

           10.2.5.2 Market Forecast

        10.2.6 Indonesia

           10.2.6.1 Market Trends

           10.2.6.2 Market Forecast

        10.2.7 Others

           10.2.7.1 Market Trends

           10.2.7.2 Market Forecast

    10.3 Europe

        10.3.1 Germany

           10.3.1.1 Market Trends

           10.3.1.2 Market Forecast

        10.3.2 France

           10.3.2.1 Market Trends

           10.3.2.2 Market Forecast

        10.3.3 United Kingdom

           10.3.3.1 Market Trends

           10.3.3.2 Market Forecast

        10.3.4 Italy

           10.3.4.1 Market Trends

           10.3.4.2 Market Forecast

        10.3.5 Spain

           10.3.5.1 Market Trends

           10.3.5.2 Market Forecast

        10.3.6 Russia

           10.3.6.1 Market Trends

           10.3.6.2 Market Forecast

        10.3.7 Others

           10.3.7.1 Market Trends

           10.3.7.2 Market Forecast

    10.4 Latin America

        10.4.1 Brazil

           10.4.1.1 Market Trends

           10.4.1.2 Market Forecast

        10.4.2 Mexico

           10.4.2.1 Market Trends

           10.4.2.2 Market Forecast

        10.4.3 Others

           10.4.3.1 Market Trends

           10.4.3.2 Market Forecast

    10.5 Middle East and Africa

        10.5.1 Market Trends

        10.5.2 Market Breakup by Country

        10.5.3 Market Forecast

11 SWOT Analysis

    11.1 Overview

    11.2 Strengths

    11.3 Weaknesses

    11.4 Opportunities

    11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

    13.1 Overview

    13.2 Bargaining Power of Buyers

    13.3 Bargaining Power of Suppliers

    13.4 Degree of Competition

    13.5 Threat of New Entrants

    13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

    15.1 Market Structure

    15.2 Key Players

    15.3 Profiles of Key Players

        15.3.1 Abbott Laboratories

           15.3.1.1 Company Overview

           15.3.1.2 Product Portfolio

           15.3.1.3 Financials

           15.3.1.4 SWOT Analysis

        15.3.2 B. Braun Melsungen AG

           15.3.2.1 Company Overview

           15.3.2.2 Product Portfolio

           15.3.2.3 SWOT Analysis

        15.3.3 BASF SE

           15.3.3.1 Company Overview

           15.3.3.2 Product Portfolio

           15.3.3.3 Financials

           15.3.3.4 SWOT Analysis

        15.3.4 Baxter International Inc.

           15.3.4.1 Company Overview

           15.3.4.2 Product Portfolio

           15.3.4.3 Financials

           15.3.4.4 SWOT Analysis

        15.3.5 Danone S.A.

           15.3.5.1 Company Overview

           15.3.5.2 Product Portfolio

           15.3.5.3 Financials

           15.3.5.4 SWOT Analysis

        15.3.6 Fresenius SE & Co. KGaA

           15.3.6.1 Company Overview

           15.3.6.2 Product Portfolio

           15.3.6.3 Financials

           15.3.6.4 SWOT Analysis

        15.3.7 Grifols S.A.

           15.3.7.1 Company Overview

           15.3.7.2 Product Portfolio

           15.3.7.3 Financials

           15.3.7.4 SWOT Analysis

        15.3.8 Koninklijke DSM N.V.

           15.3.8.1 Company Overview

           15.3.8.2 Product Portfolio

           15.3.8.3 Financials

           15.3.8.4 SWOT Analysis

        15.3.9 Meiji Holdings Co. Ltd.

           15.3.9.1 Company Overview

           15.3.9.2 Product Portfolio

           15.3.9.3 Financials

           15.3.9.4 SWOT Analysis

        15.3.10 Nestlé S.A.

           15.3.10.1 Company Overview

           15.3.10.2 Product Portfolio

           15.3.10.3 Financials

           15.3.10.4 SWOT Analysis

        15.3.11 Perrigo Company plc

           15.3.11.1 Company Overview

           15.3.11.2 Product Portfolio

           15.3.11.3 Financials

           15.3.11.4 SWOT Analysis

        15.3.12 Reckitt Benckiser Group PLC

           15.3.12.1 Company Overview

           15.3.12.2 Product Portfolio

           15.3.12.3 Financials

           15.3.12.4 SWOT Analysis